Literature DB >> 30980865

TRPM4 channel and cancer.

Yahui Gao1, Ping Liao2.   

Abstract

The TRPM4 channel has been extensively studied in cerebral diseases such as stroke, head injury and multiple sclerosis. In the heart, gain-of-function mutations of TRPM4 are a cause of familial cardiac block. Recently, evidence has emerged to support the role of TRPM4 in certain types of cancer, such as prostate cancer and large B cell lymphoma. The expression of TRPM4 could mediate certain behaviors of cancer cells such as migration and invasion. However, the mechanisms are largely unknown. As a nonselective monovalent cation channel, TRPM4 upregulation and activation enhance sodium entry, which leads to depolarization of the membrane potential. The membrane potential is critical in regulating calcium influx, and a disturbed calcium homeostasis is always associated with cancer cell behaviors. Research on TRPM4 channels in cancer is at a very early stage. In this review, we summarize the expression of TRPM4 in various cancers as well as our current understanding of TRPM4 in cancer. The potential mechanisms of the TRPM4 channel in regulating calcium homeostasis in cancer cells are further discussed in detail. Targeting the TRPM4 channel can be a novel way of managing cancer metastasis via disrupting calcium signaling pathways.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium; Cancer; Invasion; Ion channels; Migration; Proliferation

Year:  2019        PMID: 30980865     DOI: 10.1016/j.canlet.2019.04.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  NUCB2: roles in physiology and pathology.

Authors:  Qing Zhou; Ying Liu; Ranran Feng; Wenling Zhang
Journal:  J Physiol Biochem       Date:  2022-06-09       Impact factor: 5.080

2.  A Pancancer Study of PIEZO1 as a Prognosis and Immune Biomarker of Human Tumors.

Authors:  Yunhui Wu; Jingying Zhang; Can Hou; Hongyu Wang; Min Zhu; Xin Yao
Journal:  J Oncol       Date:  2022-06-14       Impact factor: 4.501

Review 3.  The regulatory and modulatory roles of TRP family channels in malignant tumors and relevant therapeutic strategies.

Authors:  Tiecheng Zhong; Wenxin Zhang; Hongjie Guo; Xiaohui Pan; Xi Chen; Qiaojun He; Bo Yang; Ling Ding
Journal:  Acta Pharm Sin B       Date:  2021-11-05       Impact factor: 14.903

4.  Development and characterization of a monoclonal antibody blocking human TRPM4 channel.

Authors:  See Wee Low; Yahui Gao; Shunhui Wei; Bo Chen; Bernd Nilius; Ping Liao
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

5.  m6A RNA hypermethylation-induced BACE2 boosts intracellular calcium release and accelerates tumorigenesis of ocular melanoma.

Authors:  Fanglin He; Jie Yu; Jie Yang; Shaoyun Wang; Ai Zhuang; Hanhan Shi; Xiang Gu; Xiaofang Xu; Peiwei Chai; Renbing Jia
Journal:  Mol Ther       Date:  2021-02-15       Impact factor: 12.910

Review 6.  TRPM Channels in Human Diseases.

Authors:  Ivanka Jimenez; Yolanda Prado; Felipe Marchant; Carolina Otero; Felipe Eltit; Claudio Cabello-Verrugio; Oscar Cerda; Felipe Simon
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

7.  Mechanisms and significance of Ca2+ entry through TRPC channels.

Authors:  Bernadett Bacsa; Oleksandra Tiapko; Thomas Stockner; Klaus Groschner
Journal:  Curr Opin Physiol       Date:  2020-06-29

Review 8.  TRP Channels in Digestive Tract Cancers.

Authors:  Paulina Stokłosa; Anna Borgström; Sven Kappel; Christine Peinelt
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

Review 9.  Membrane Transporters and Channels in Melanoma.

Authors:  Ines Böhme; Roland Schönherr; Jürgen Eberle; Anja Katrin Bosserhoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

10.  Estrogen Aggravates Tumor Growth in a Diffuse Gastric Cancer Xenograft Model.

Authors:  Sunyi Lee; Kyoung Mee Kim; Seung Yeon Lee; Joohee Jung
Journal:  Pathol Oncol Res       Date:  2021-04-16       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.